Article Information
History
- June 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jacob Pitcovskia,c,
- Nady Gruzdeva,
- Anna Abzacha,
- Chen Katza,
- Ran Ben-Adivaa,
- Michal Brand Schwartza,
- Itamar Yadida,c,
- Hadar Haviva,
- Irena Rapoporta,
- Itai Blocha,
- Roy Shadmonb,
- Zohar Eitanb,
- Dalia Eliahua,
- Talia Hilela,
- Morris Lasterb,
- Sigal Kremer Talb,
- Tamara Byk Tennenbaumb and
- Ehud Shahara,c,*
- aMIGAL Research Institute in the Galilee Kiryat Shmona, Israel
- bMigVax Ltd
- cTel-Hai Academic College, Upper Galilee, Israel
- ↵*Corresponding author: Ehud Shahar; email: ehudsha{at}migal.org.il
Posted June 09, 2021.
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
